Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake... We evaluated whether the anxiolytic effects of selective serotonin reuptake inhibitors (SSRIs) in the rat ultrasonic vocalization (USV) test are preferentially mediated by (indirect) activation of 5-HT 1A , 5-HT 1B/1D , 5-HT 2A , 5-HT 3 or 5-HT 4 receptors. The SSRIs, paroxetine (ED 50 in mg/kg, IP: 6.9), citalopram (6.5), fluvoxamine (11.7) and fluoxetine (>30), dose dependently reduced shock-induced USV. The effects of paroxetine (3.0 mg/kg, IP) were not blocked by the selective 5-HT 1A receptor antagonist, WAY-100635 (3.0 mg/kg, IP), the 5-HT 1B/1D receptor antagonist, GR 127935 (30 mg/kg, IP), the nonselective 5-HT 2A receptor antagonists, ritanserin (3.0 mg/kg, IP) and ketanserin (1.0 mg/kg, IP), the 5-HT 3 receptor antagonist, ondansetron (0.1 mg/kg, IP), or the 5-HT 4 receptor antagonist, GR 125487D (3.0 mg/kg, SC). In contrast, the selective 5-HT 2A receptor antagonist, MDL 100,907 (0.1 mg/kg, IP), completely prevented the paroxetine-induced reduction of USV. Under similar conditions, WAY-100635 blocked the anxiolytic-like effects of the selective 5-HT 1A receptor agonist, 8-OH-DPAT ((±)-8-hydroxy-2-(di- n -propylamino)tetralin, 1.0 mg/kg, IP), and ritanserin, ketanserin, and MDL 100,907 blocked the anxiolytic-like effects of the mixed 5-HT 2A/2C receptor agonist, DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, 3.0 mg/kg, IP). WAY-100635 (1.0 mg/kg, IP) in combination with ritanserin (3.0 mg/kg, IP), but not ondansetron (0.1 mg/kg, IP), GR 125487D (3.0 mg/ kg, SC), or GR 127935 (30 mg/kg, IP), attenuated the USV reducing effects of paroxetine. Although the results suggest that selective stimulation of 5-HT 1A and 5-HT 2A receptors produces a decrease of USV, we postulate that only 5-HT 2A receptors play a pivotal role in the effects of SSRIs in this model of anxiety. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

Schreiber, R.; Melon, C.; De Vry, Jean
Psychopharmacology , Volume 135 (4) – Feb 1, 1998
Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/the-role-of-5-ht-receptor-subtypes-in-the-anxiolytic-effects-of-CwXYIswIl9

References (32)

Publisher
Springer Journals
Copyright
Copyright © 1998 by Springer-Verlag Berlin Heidelberg
Subject
Legacy
ISSN
0033-3158
eISSN
1432-2072
DOI
10.1007/s002130050526
Publisher site
See Article on Publisher Site

Abstract

We evaluated whether the anxiolytic effects of selective serotonin reuptake inhibitors (SSRIs) in the rat ultrasonic vocalization (USV) test are preferentially mediated by (indirect) activation of 5-HT 1A , 5-HT 1B/1D , 5-HT 2A , 5-HT 3 or 5-HT 4 receptors. The SSRIs, paroxetine (ED 50 in mg/kg, IP: 6.9), citalopram (6.5), fluvoxamine (11.7) and fluoxetine (>30), dose dependently reduced shock-induced USV. The effects of paroxetine (3.0 mg/kg, IP) were not blocked by the selective 5-HT 1A receptor antagonist, WAY-100635 (3.0 mg/kg, IP), the 5-HT 1B/1D receptor antagonist, GR 127935 (30 mg/kg, IP), the nonselective 5-HT 2A receptor antagonists, ritanserin (3.0 mg/kg, IP) and ketanserin (1.0 mg/kg, IP), the 5-HT 3 receptor antagonist, ondansetron (0.1 mg/kg, IP), or the 5-HT 4 receptor antagonist, GR 125487D (3.0 mg/kg, SC). In contrast, the selective 5-HT 2A receptor antagonist, MDL 100,907 (0.1 mg/kg, IP), completely prevented the paroxetine-induced reduction of USV. Under similar conditions, WAY-100635 blocked the anxiolytic-like effects of the selective 5-HT 1A receptor agonist, 8-OH-DPAT ((±)-8-hydroxy-2-(di- n -propylamino)tetralin, 1.0 mg/kg, IP), and ritanserin, ketanserin, and MDL 100,907 blocked the anxiolytic-like effects of the mixed 5-HT 2A/2C receptor agonist, DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, 3.0 mg/kg, IP). WAY-100635 (1.0 mg/kg, IP) in combination with ritanserin (3.0 mg/kg, IP), but not ondansetron (0.1 mg/kg, IP), GR 125487D (3.0 mg/ kg, SC), or GR 127935 (30 mg/kg, IP), attenuated the USV reducing effects of paroxetine. Although the results suggest that selective stimulation of 5-HT 1A and 5-HT 2A receptors produces a decrease of USV, we postulate that only 5-HT 2A receptors play a pivotal role in the effects of SSRIs in this model of anxiety.

Journal

Psychopharmacology – Springer Journals

Published: Feb 1, 1998

There are no references for this article.